BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3713642)

  • 1. Phase II study: the combination DTIC, BCNU, actinomycin D, and vincristine in disseminated malignant melanoma.
    Creagan ET; Schutt AJ; Long HJ; Green SJ
    Med Pediatr Oncol; 1986; 14(2):86-7. PubMed ID: 3713642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dibromodulcitol (DBD), DTIC, and actinomycin-D in disseminated malignant melanoma. A phase I-II clinical trial.
    Samson MK; Haas CD; Baker LH; Cummings G
    Am J Clin Oncol; 1985 Apr; 8(2):167-71. PubMed ID: 3834791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
    Kirchner HH; Atzpodien J; Poliwoda H
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of bleomycin, actinomycin D, DTIC and vindesine in disseminated malignant melanoma.
    Mulder NH; Sleijfer DT; Smit JM; De Vries EG; Willemse PH; Koops HS
    Eur J Cancer Clin Oncol; 1986 Jul; 22(7):879-81. PubMed ID: 2429842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen.
    Atzpodien J; Lopez Hänninen E; Kirchner H; Franzke A; Körfer A; Volkenandt M; Duensing S; Schomburg A; Chaitchik S; Poliwoda H
    Eur J Cancer; 1995 Jun; 31A(6):876-81. PubMed ID: 7646914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.
    Propper DJ; Braybrooke JP; Levitt NC; O'Byrne K; Christodoulos K; Han C; Talbot DC; Ganesan TS; Harris AL
    Br J Cancer; 2000 Jun; 82(11):1759-63. PubMed ID: 10839287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
    Van Dyk JJ; Falkson G
    Med Pediatr Oncol; 1975; 1(2):107-11. PubMed ID: 1228411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DTIC and combination therapy for melanoma. II. Escalating schedules of DTIC with BCNU, CCNU, and vincristine.
    Hill GJ; Metter GE; Krementz ET; Fletcher WS; Golomb FM; Ramirez G; Grage TB; Moss SE
    Cancer Treat Rep; 1979; 63(11-12):1989-92. PubMed ID: 393384
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination chemotherapy plus levamisole in the treatment of disseminated malignant melanoma. A Southwest Oncology Group study.
    Costanzi JJ; Fletcher WS; Balcerzak SP; Taylor S; Eyre HJ; O'Bryan RM; Al-Sarraf M; Frank J
    Cancer; 1984 Feb; 53(4):833-6. PubMed ID: 6362830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study.
    Jelić S; Babovic N; Kovcin V; Milicevic N; Milanovic N; Popov I; Radosavljevic D
    Melanoma Res; 2002 Feb; 12(1):91-8. PubMed ID: 11828263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanoma.
    Creagan ET; Suman VJ; Dalton RJ; Pitot HC; Long HJ; Veeder MH; Vukov AM; Rowland KM; Krook JE; Michalak JC
    J Clin Oncol; 1999 Jun; 17(6):1884-90. PubMed ID: 10561229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination chemotherapy of disseminated skin melanoma with nitrosomethylurea].
    Perevodchikova NJ; Moros LW; Kogonia LM
    Arch Geschwulstforsch; 1986; 56(4):273-81. PubMed ID: 3530176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I--II study of intermittent bolus administration of DTIC and actinomycin D in metastatic malignant melanoma.
    Samson MK; Baker LH; Talley RW; Fraile RJ; McDonald B
    Cancer Treat Rep; 1978 Aug; 62(8):1223-5. PubMed ID: 356980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
    Serrone L; Zeuli M; Sega FM; Cognetti F
    J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-1-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanoma.
    Moon JH; Gailani S; Cooper MR; Hayes DM; Rege VB; Blom J; Falkson G; Maurice P; Brunner K; Glidewell O; Holland JF
    Cancer; 1975 Feb; 35(2):368-71. PubMed ID: 1111913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy with a nitrosourea-based protocol in advanced malignant melanoma.
    Karakousis C; Blumenson L
    Eur J Cancer; 1993; 29A(13):1831-5. PubMed ID: 8260235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).
    Carter RD; Krementz ET; Hill GJ; Metter GE; Fletcher WS; Golomb FM; Grage TB; Minton JP; Sparks FC
    Cancer Treat Rep; 1976 May; 60(5):601-9. PubMed ID: 991149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cis-platinum and DTIC combination chemotherapy in disseminated melanoma. A Southwest Oncology Group Study.
    Fletcher WS; Green S; Fletcher JR; Dana B; Jewell W; Townsend RA
    Am J Clin Oncol; 1988 Oct; 11(5):589-93. PubMed ID: 3177261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential therapy with dacarbazine and carmustine: a phase I study.
    Mitchell RB; Dolan ME; Janisch L; Vogelzang NJ; Ratain MJ; Schilsky RL
    Cancer Chemother Pharmacol; 1994; 34(6):509-14. PubMed ID: 7923562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma.
    Pyrhönen S; Hahka-Kemppinen M; Muhonen T
    J Clin Oncol; 1992 Dec; 10(12):1919-26. PubMed ID: 1280673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.